CCL3 and neoplasm: Phinney et al. [28] then showed in CT26 and MC38 flank-tumor models (Balb/c and C57BL/6 mice) that the MAPK-activated protein kinase 2 (MK2) pathway controls CCL3 production in both tumor cells and macrophages.